Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

NJSPL Announces 2025 Summer Interns

The New Jersey State Policy Lab is excited to announce that the fourth annual summer internship program has begun at the Bloustein School of Planning and Public Policy. Six students have been selected to participate in this year’s program, which will encompass ten...

“Work Trends RU” Podcast with First Lady Tammy Murphy

In the latest episode of the Heldrich Center for Workforce Development's new podcast series, "Work Trends RU," Tammy Murphy, First Lady of New Jersey, discusses her leadership in maternal and infant health in New Jersey, the impacts of the Nurture NJ and Family...

NJSPL: Chatbot for NJ SNAP Services

Working Toward an Equitable Chatbot for NJ SNAP Services New Jersey State Policy Lab, Vignesh Krishnan, Yonaira Rivera, Vivek Singh In New Jersey, Supplemental Nutrition Assistance Program (SNAP) services are vital for supporting food security among low-income...

Bloustein School announces faculty promotions

The Bloustein School is pleased to announce the recent promotion of several school faculty. Amy E. Underhill Abruzzi, Ph.D, MPH, MLS, CPH, MCHES, Anita Franzione, DrPH, and Alexandra Lopez, M.A. have all been promoted to Full Professor of Teaching. “These promotions...

MPI Grad Students Present MOMCare with AI

On Friday, May 16th, NJ Big Data Alliance held the 12th Annual NJBDA Symposium titled "Empowered by AI: Innovation and the Rise of the Augmented Workforce." The paper titled "MOMCare: An AI Chatbot for Postpartum Depression Counselling" was presented. And, the...